Mucosally induced systemic T cell unresponsiveness to ovalbumin requires CD40 ligand-CD40 interactions

Journal of Immunology

Volumn 162, Issue 4, 1999, Pages 1904-1909

  Kweon, Mi Na ^a,c   Fujihashi, Kohtaro ^a   Wakatsuki, Yoshio ^b   Koga, Toshiya ^a   Yamamoto, Masafumi ^c   McGhee, Jerry R ^a   Kiyono, Hiroshi ^a,c  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b KYOTO UNIVERSITY   (Japan)

^c OSAKA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 ANTIGEN; LIGAND; OVALBUMIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIGEN SPECIFICITY; ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE PRODUCTION; HELPER CELL; IMMUNOLOGICAL TOLERANCE; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE;

ADMINISTRATION, ORAL; ANIMALS; ANTIGENS, CD40; B-LYMPHOCYTES; CD4-POSITIVE T-LYMPHOCYTES; CD40 LIGAND; CYTOKINES; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; DOWN-REGULATION; IMMUNE TOLERANCE; LIGANDS; LYMPHOCYTE COOPERATION; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED C57BL; MICE, INBRED STRAINS; MICE, KNOCKOUT; MOUTH MUCOSA; OVALBUMIN; T-LYMPHOCYTE SUBSETS; TH1 CELLS; TH2 CELLS; TRANSFECTION;

EID: 0033557712     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Armitage, R. J., W. C. Fanslow, L. Strockbine, T. A. Sato, K. N. Clifford, B. M. Macduff, D. M. Anderson, S. D. Gimpel, T. Davis-Smith, and C. R. Maliszewski. 1992. Molecular and biological characterization of a murine ligand for CD40. Nature 357:80.
2. Caux, C., C. Massacrier, B. Vanbervliet, B. Dubois, C. Van Kooten, I. Durand, and J. Banchereau. 1994. Activation of human dendritic cells through CD40 cross-linking. J. Exp. Med. 180:1263.
3. Peguet-Navarro, J., C. Dalbiez-Gauthier, F. M. Rattis, C. Van Kooten, J. Banchereau, and D. Schmitt. 1995. Functional expression of CD40 antigen on human epidermal Langerhans cells. J. Immunol. 155:4241.
4. Xu, J., T. M. Foy, J. D. Laman, E. A. Elliott, J. J. Dunn, T. J. Waldschmidt, J. Elsemore, R. J. Noelle, and R. A. Flavell. 1994. Mice deficient for the CD40 ligand. Immunity 1:423.
5. Renshaw, B. R., W. C. Fanslow 3rd, R. J. Armitage, K. A. Campbell, D. Liggitt, B. Wright, B. L. Davison, and C. R. Maliszewski. 1994. Humoral immune responses in CD40 ligand-deficient mice. J. Exp. Med. 180:1889.
6. Campbell, K. A., P. J. Ovendale, M. K. Kennedy, W. C. Fanslow, S. G. Reed, and C. R. Maliszewski. 1996. CD40 ligand is required for protective cell-mediated immunity to Leishmania major. Immunity 4:283.
7. Kennedy, M. K., K. S. Picha, W. C. Fanslow, K. H. Grabstein, M. R. Alderson, K. N. Clifford, W. A. Chin, and K. M. Mohler. 1996. CD40/CD40 ligand interactions are required for T cell-dependent production of interleukin-12 by mouse macrophages. Eur. J. Immunol. 26:370.
8. Khoury, S. J., W. W. Hancock, and H. L. Weiner. 1992. Oral tolerance to myelin basic protein and natural recovery from experimental autoimmune encephalomyelitis are associated with downregulation of inflammatory cytokines and differential upregulation of transforming growth factor β. interleukin 4, and prostaglandin E expression in the brain. J. Exp. Med. 176:1355.
9. Kweon, M.-N., K. Fujihashi, J. L. VanCott, K. Higuchi, M. Yamamoto, J. R. McGhee, and H. Kiyono. 1998. Lack of orally induced systemic unresponsiveness in IFN-γ knockout mice. J. Immunol. 160:1687.
10. Tomasi, T. B., Jr. 1980. Oral tolerance. Transplantation 29:353.
11. + T cell-dependent immune deviation resulting in selective suppression of immunoglobulin E production. J. Exp. Med. 178:889.
12. Husby, S., J. Mestecky, Z. Moldoveanu, S. Holland, and C. O. Elson. 1994. Oral tolerance in humans: T cell but not B cell tolerance to a soluble protein antigen. J. Immunol. 152:4663.
13. Chen, Y., J. Inobe, R. Marks, P. Gonnella, V. K. Kuchroo, and H. L. Weiner. 1995. Peripheral deletion of antigen-reactive T cells in oral tolerance. Nature 376:177.
14. + T cells anergized by high dose feeding establish oral tolerance to antibody responses when transferred in SCID and nude mice J. Immunol. 154: 6238.
15. + cells on the induction and maintenance of oral tolerance. Cell. Immunol. 163:19.
16. Vistica, B. P., N. P. Chanaud 3rd, N. Felix, R. R. Caspi, L. V. Rizzo, R. B. Nussenblatt, and I. Gery. 1996. CD8 T-cells are not essential for the induction of "low-dose" oral tolerance. Clin. Immunol. Immunopath. 78:196.
17. +/+ cells. J. Immunol. 154:6252.
18. Samoilova, E. B., J. L. Horton, H. Zhang, S. J. Khoury, H. L. Weiner, and Y. Chen. 1998. CTLA-4 is required for the induction of high dose oral tolerance. Intern. Immunol. 10:491.
19. Tang, A., T. A. Judge, and L. A. Turka. 1997. Blockade of CD40-CD40 ligand pathway induces tolerance in murine contact hypersensitivity. Eur. J. Immunol. 27:3143.
20. Bowen, F., J. Haluskey, and H. Quill. 1995. Altered CD40 ligand induction in tolerant T lymphocytes. Eur. J. Immunol. 25:2830.
21. Yamamoto, S., Y. Takeda, M. Yamamoto, H. Kurazono, K. Imaoka, M. Yamamoto, K. Fujihashi, M. Noda, H. Kiyono, and J. R. McGhee. 1997. Mutants in the ADP-ribosyltransferase cleft of cholera toxin lack diarrheagenicity but retain adjuvanticity. J. Exp. Med. 185:1203.
22. Yamamoto, M., K. Fujihashi, K. Kawabata, J. R. McGhee, and H. Kiyono. 1998. A mucosal intranet: Intestinal epithelial cells down-regulate intraepithelial, but not peripheral, T lymphocytes. J. Immunol. 160:2188.
23. + T cells for helper activity. Intern. Immunol. 5:1473.
24. Wakatsuki, Y., M. F. Neurath, E. E. Max, and W. Strober. 1994. The B cell-specific transcription factor BSAP regulates B cell proliferation. J. Exp. Med. 179:1099.
25. Melamed, D., and A. Friedman. 1993. Direct evidence for anergy in T lymphocytes tolerized by oral administration of ovalbumin. Eur. J. Immunol. 23:935.
26. Whitacre, C. C., I. E. Gienapp, C. G. Orosz, and D. M. Bitar. 1991. Oral tolerance in experimental autoimmune encephalomyelitis. III. Evidence for clonal anergy. J. Immunol. 147:2155.
27. Quill, H. 1996. Anergy as a mechanism of peripheral T cell tolerance. J. Immunol. 156:1325.
28. Jenkins, M. K., and R. H. Schwartz. 1987. Antigen presentation by chemically modified splenocytes induces antigen-specific T cell unresponsiveness in vitro and in vivo. J. Exp. Med. 165:302.
29. Grewal, I. S., H. G. Foellmer, K. D. Grewal, J. Xu, F. Hardardottir, J. L. Baron, C. A. Janeway, Jr., and R. A. Flavell. 1996. Requirement for CD40 ligand in costimulation induction T cell activation, and experimental allergic encephalomyelitis. Science 273:1864.
30. Ranheim, E. A., and T. J. Kipps. 1993. Activated T cells induce expression of B7/BB1 on normal or leukemic B cells through a CD40-dependent signal. J. Exp. Med. 177.925.
31. Krummel, M. F., and J. P. Allison. 1995. CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation. J. Exp. Med. 182:459.
32. Perez, V. L., L. Van Parijs, A. Biuckians, X. X. Zheng, T. B. Strom, and A. K. Abbas. 1997. Induction of peripheral T cell tolerance in vivo requires CTLA-4 engagement. Immunity 6:411.
33. + T cells via CD40 ligand. Proc. Natl. Acad. Sci. USA 94:599.
34. Soong, L., J. C. Xu. I. S. Grewal, P. Kima, J. Sun, B. J. Longley, Jr., N. H. Ruddle, D. McMahon-Pratt, and R. A. Flavell. 1996. Disruption of CD40-CD40 ligand interactions results in an enhanced susceptibility to Leishmania amazonensis infection. Immunity 4:263.
35. Weiner, H. L. 1997. Oral tolerance: immune mechanisms and treatment of autoimmune diseases. Immunol. Today 18:335.
36. Marth, T., W. Strober, and B. L. Kelsall. 1996. High dose oral tolerance in ovalbumin TCR-transgenic mice: systemic neutralization of IL-12 augments TGF-β secretion and T cell apoptosis. J. Immunol. 157:2348.
37. Zhang, Z., and J. G. Michael. 1990. Orally inducible immune unresponsiveness is abrogated by IFN-γ treatment. J. Immunol. 144:4163.
38. Santos, E. M., A. al-Sabbagh, A. Londono, and H. L. Weiner. 1994. Oral tolerance to myelin basic protein induces regulalory TGF-β-secreting T cells in Peyer's patches of SJI mice. Cell. Immunol. 157:439.
39. Rennert, P. D., J. L. Browning, R. Mebius, F. Mackay, and P. S. Hochman. 1996. Surface lymphotoxin α/β complex is required for the development of peripheral lymphoid organs. J. Exp. Med. 184:1999.
40. Gonnella, P. A., Y. Chen, J. Inohe, Y. Komagata, M. Quartulli, and H. E. Weiner. 1998. In situ immune response in gut-associated lymphoid tissue (GALT) following oral antigen in TCR-transgenic mice. J. Immunol. 160:4708.
41. Barone, K. S., D. D. Tolarova, I. Ormsby, T. Doetschman, and J. G. Michael. 1998. Induction of oral tolerance in TGF-β1 null mice. J. Immunol. 161:154.
42. + T cells: IL-4 and IFN-γ have opposing effects, while TGF-β positively regulates its own production. J. Immunol. 160:5719.